News
Innate lymphoid cells, which curiously behave like T cells even though they don’t recognize specific antigens, show promise as a potential cancer therapeutic.
Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...
Modern unhealthy lifestyles and dietary habits have led to a yearly increase in the incidence of metabolism-related liver ...
B lymphocytes exhibit dual roles in tumorigenesis, acting as both allies and adversaries in the tumor microenvironment (TME).
For Poolbeg Pharma, the question is not simply whether it can fund its ambitions, but whether its pipeline can justify them.
A new type of immunotherapy that targets aggressive blood cancers shows promising results alongside manageable side effects, ...
Allogeneic CAR-T cell therapy is produced using CRISPR gene editing from cells donated by healthy individuals.
A novel machine learning model enhances colorectal cancer (CRC) prognosis and immunotherapy response prediction by ...
A new type of immunotherapy that targets aggressive blood cancers shows promising results alongside manageable side effects, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results